<DOC>
	<DOCNO>NCT02958462</DOCNO>
	<brief_summary>The use genomics functional translational study identify diagnose patient precursor feature myeloid neoplasms inherit bone marrow failure syndrome .</brief_summary>
	<brief_title>Pre-myeloid Cancer Bone Marrow Failure Clinic Study</brief_title>
	<detailed_description>The pre-myeloid cancer bone marrow failure clinic individualized medicine clinic conceptualize early detection myeloid malignancy , myelodysplastic syndrome ( MDS ) , myeloproliferative neoplasm ( MPN ) , MDS/MPN overlap syndrome acute myeloid leukemia ( AML ) . Using next-generation sequencing technology , clonal hematopoietic stem cell change detect early myeloid malignancy . These change currently classify follow : 1 . Idiopathic cytopenias unclear significance ( ICUS ) . 2 . Clonal cytopenia unclear significance ( CCUS ) . 3 . Clonal hematopoiesis indeterminate prognosis ( CHIP ) . 4 . Bone marrow failure syndrome risk clonal myeloid transformation . 5 . Familial/Germline syndrome increase risk myeloid malignancy . This clinic blend next-generation sequence technology functional study help identify , prognosticate define management plan ; include early intervention strategy , affect patient .</detailed_description>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<criteria>Patients : Idiopathic cytopenia unclear significance ( ICUS ) Clonal hematopoiesis indeterminate significance ( CHIP ) Age related clonal hematopoiesis ( ARCH ) Clonal cytopenia unclear significance ( CCUS ) Marrow failure syndromes myeloid malignancy predisposition telomere dysfunction , chromosomal breakage disorder , etc . Germ line inherit syndrome risk malignant transformation Low Risk Myelodysplastic Syndromes ( MDS ) Patients unable understand sign Informed Consent Form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>